The Readout Loud

298: A dilemma in ALS, the first MASH drug, & why gene therapy is hard

Mar 14, 2024
Guest
Holly Fernandez Lynch
Bioethicist discusses ALS treatment dilemma, gene therapy challenges, CAR-T cancer treatments, & first drug for liver disease. Pi Day pie contest at STAT Boston HQ adds fun twist to the episode. Ethics of drug withdrawal explored in light of FDA's authority in drug approvals.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Pi Day Contest at STAT Boston HQ Office
01:53 • 2min
3
The Evolution of Gene Therapies: Balancing Promise and Caution
03:30 • 9min
4
Landmark Approval of First Medicine for Fatty Liver Disease
12:37 • 4min
5
Ethical Dilemma in ALS Treatment and Drug Withdrawal Decision
16:39 • 3min
6
FDA's Authority in Drug Approval and Withdrawal
19:52 • 15min